Replimune Group Inc.(REPL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

REPL Replimune Group Inc.

交易中 07-31 15:27:39 EDT

10.09

-0.01

-0.10%

最高10.35	最低9.85	成交量25.54万
今开10.19	昨收10.10	日振幅4.95%
总市值6.89亿	流通市值4.52亿	总股本6,832万
成交额258.36万	换手率0.57%	流通股本4,479万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"REPL","market":"US","secType":"STK","nameCN":"Replimune Group Inc.","latestPrice":10.09,"timestamp":1722454030957,"preClose":10.1,"halted":0,"volume":255359,"delay":0,"floatShares":44789000,"shares":68321396,"eps":-3.241615,"marketStatus":"交易中","marketStatusCode":2,"change":-0.01,"latestTime":"07-31 15:27:39 EDT","open":10.19,"high":10.35,"low":9.85,"amount":2583649.584685,"amplitude":0.049505,"askPrice":10.13,"askSize":352,"bidPrice":10.07,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-3.241615,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1722456000000},"adr":0,"listingDate":1532059200000,"adjPreClose":10.1,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":10.26,"preClose":10.1,"latestTime":"17:19 EDT","volume":16689,"amount":168586.4,"timestamp":1722374353718},"volumeRatio":0.515592,"impliedVol":0.9527,"impliedVolPercentile":0.3214},"requestUrl":"/m/hq/s/REPL","defaultTab":"news","newsList":[{"id":"2455610479","title":"Replimune Group Inc    预计每股亏损 85 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2455610479","media":"Reuters","labels":["preview"],"top":-1,"share":"https://www.laohu8.com/m/news/2455610479?lang=zh_cn&edition=full","pubTime":"2024-07-31 02:38","pubTimestamp":1722364693,"startTime":"0","endTime":"0","summary":"   * Replimune Group Inc    将于8月1日公布截至2024年6月30日的财报() 预计季度营收将保持不变。*    * LSEG 的分析师平均预计 Replimune Group Inc 每股亏损 85 美分。* 目前，分析师对该公司股票的平均评级为 \"买入\"，建议分类为 9 个 \"强烈买入 \"或 \"买入\"，没有 \"持有\"，也没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Replimune Group Inc 的 12 个月目标价中位数为 13.50 美元，高于其上次收盘价 10.06 美元。7月30日 - 上一季度业绩。除非另有说明，所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REPL"],"gpt_icon":0},{"id":"2454801949","title":"Replimune Group, Inc.盘中异动 股价大涨5.17%报10.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454801949","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454801949?lang=zh_cn&edition=full","pubTime":"2024-07-26 00:18","pubTimestamp":1721924281,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日00时18分，Replimune Group, Inc.股票出现波动，股价快速上涨5.17%。截至发稿，该股报10.78美元/股，成交量24.4708万股，换手率0.36%，振幅6.83%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Viking Therapeutics, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Exicure, Inc.较为活跃，换手率分别为4041.60%、543.72%、277.19%，振幅较大的相关个股有Psyence Biomedical Ltd.、Exicure, Inc.、Salarius Pharmaceuticals, Inc.，振幅分别为152.48%、132.26%、98.60%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726001801941faabf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726001801941faabf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2452592196","title":"Replimune Group, Inc.盘中异动 下午盘股价大跌5.15%报10.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452592196","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452592196?lang=zh_cn&edition=full","pubTime":"2024-07-18 03:00","pubTimestamp":1721242824,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日03时00分，Replimune Group, Inc.股票出现异动，股价急速跳水5.15%。截至发稿，该股报10.49美元/股，成交量34.7634万股，换手率0.57%，振幅5.97%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为1.56%。其相关个股中，Aptevo Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Moolec Science Sa C/Wts 涨幅较大，Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃，换手率分别为3888.16%、1438.14%、320.28%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Cyclerion Therapeutics, Inc.、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为76.39%、48.13%、46.96%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718030024af92ce21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718030024af92ce21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2451628172","title":"Replimune Group, Inc.盘中异动 早盘快速上涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451628172","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451628172?lang=zh_cn&edition=full","pubTime":"2024-07-15 21:32","pubTimestamp":1721050332,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日21时32分，Replimune Group, Inc.股票出现异动，股价大幅拉升5.31%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Scinai Immunotherapeutics Ltd、Aeon Biopharma, Inc.、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Scinai Immunotherapeutics Ltd、Artelo Biosciences, Inc.、Qualigen Therapeutics, Inc.较为活跃，换手率分别为998.68%、92.61%、47.29%，振幅较大的相关个股有Scinai Immunotherapeutics Ltd、Aeon Biopharma, Inc.、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为17.98%、13.93%、11.17%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715213213941f70c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715213213941f70c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2450536812","title":"Replimune Group, Inc.盘中异动 大幅上涨5.24%报10.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450536812","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450536812?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:32","pubTimestamp":1720791163,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时32分，Replimune Group, Inc.股票出现波动，股价大幅拉升5.24%。截至发稿，该股报10.44美元/股，成交量1.5634万股，换手率0.03%，振幅3.43%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Zura Bio Limited C/Wts 、Qualigen Therapeutics, Inc.、Instil Bio, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Clearmind Medicine Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为645.25%、74.41%、24.24%，振幅较大的相关个股有Zura Bio Limited C/Wts 、Engene Holdings Inc.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为20.00%、14.29%、13.95%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213243aef97a5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213243aef97a5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2450361143","title":"Replimune Group, Inc.盘中异动 早盘股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450361143","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450361143?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:56","pubTimestamp":1720709795,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时56分，Replimune Group, Inc.股票出现异动，股价快速上涨5.44%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。其相关个股中，Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc、Omniab Inc C/Wts 涨幅较大，Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为588.16%、513.98%、358.14%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited，振幅分别为149.07%、88.60%、82.31%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711225636aef94076&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711225636aef94076&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2450720610","title":"Replimune Group, Inc.盘中异动 临近收盘快速拉升5.09%报8.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450720610","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450720610?lang=zh_cn&edition=full","pubTime":"2024-07-10 03:34","pubTimestamp":1720553657,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日03时34分，Replimune Group, Inc.股票出现异动，股价快速拉升5.09%。截至发稿，该股报8.87美元/股，成交量33.8019万股，换手率0.55%，振幅7.94%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。其相关个股中，Soligenix, Inc.、Uniqure N.V.、180 Life Sciences Corp.涨幅较大，Soligenix, Inc.、180 Life Sciences Corp.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为13278.65%、3242.54%、368.71%，振幅较大的相关个股有Soligenix, Inc.、180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为468.99%、196.29%、134.00%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100334189681b360&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100334189681b360&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2448949092","title":"Replimune Group, Inc.盘中异动 下午盘大幅上涨5.00%报9.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448949092","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448949092?lang=zh_cn&edition=full","pubTime":"2024-07-02 02:44","pubTimestamp":1719859478,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日02时44分，Replimune Group, Inc.股票出现异动，股价大幅上涨5.00%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Senti Biosciences, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Senti Biosciences, Inc.、Geovax Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为771.54%、202.74%、124.21%，振幅较大的相关个股有Senti Biosciences, Inc.、Cingulate Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为101.49%、82.81%、56.57%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702024438af900bca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702024438af900bca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2445003100","title":"Replimune Group, Inc.盘中异动 早盘股价大涨5.00%报8.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445003100","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445003100?lang=zh_cn&edition=full","pubTime":"2024-06-24 22:55","pubTimestamp":1719240957,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日22时55分，Replimune Group, Inc.股票出现波动，股价快速上涨5.00%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为1.38%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、阿里拉姆制药、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Revelation Biosciences, Inc.、Geovax Labs, Inc.、Effector Therapeutics, Inc.较为活跃，换手率分别为1729.14%、135.18%、80.32%，振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Revelation Biosciences Inc C/Wts 10/01/2027 、Revelation Biosciences, Inc.，振幅分别为139.27%、59.54%、58.29%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624225557aef65430&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624225557aef65430&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2445919763","title":"Replimune Group, Inc.盘中异动 早盘大幅拉升5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445919763","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445919763?lang=zh_cn&edition=full","pubTime":"2024-06-21 21:50","pubTimestamp":1718977836,"startTime":"0","endTime":"0","summary":"北京时间2024年06月21日21时50分，Replimune Group, Inc.股票出现异动，股价快速拉升5.46%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Ocean Biomedical Inc C/Wts 14/02/2028 、Sarepta Therapeutics, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Mustang Bio, Inc.、Kintara Therapeutics, Inc.较为活跃，换手率分别为201.41%、37.33%、36.22%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Mustang Bio, Inc.、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为52.38%、34.88%、26.13%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062121503696815cac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062121503696815cac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2443676290","title":"Replimune Group, Inc.盘中异动 股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443676290","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443676290?lang=zh_cn&edition=full","pubTime":"2024-06-14 22:19","pubTimestamp":1718374753,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日22时19分，Replimune Group, Inc.股票出现波动，股价快速下跌5.29%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Biocardia Inc C/Wts 06/08/2024、Cns Pharmaceuticals, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Longeveron Inc.、Bio-Path Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为726.96%、201.97%、183.03%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Kyverna Therapeutics, Inc.，振幅分别为88.40%、57.51%、39.40%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614221913941eeae0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614221913941eeae0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2443636152","title":"BUZZ-Replimune 获得 1 亿美元 PIPE 融资后反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=2443636152","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443636152?lang=zh_cn&edition=full","pubTime":"2024-06-14 00:53","pubTimestamp":1718297614,"startTime":"0","endTime":"0","summary":"    6月13日 - ** 生物技术公司Replimune Group   周四私募融资1亿美元，股价上涨8.3%，报9.55美元。** 公司表示将利用所得资金 \"全面扩大 \"RP1 在皮肤癌领域的商业化，并用于营运资金和一般用途。** 12月5日，RP1与Regeneron公司  的抗体药物Libtayo联用在中期研究中失败后，REPL暴跌  45%至6.75美元。** Replimune 拥有约 6 140 万股已发行股票和约 5 680 万股公众流通股 - LSEG** 该公司于 2018 年以 15 美元的价格首次公开募股，其股价最高曾达到 54.85 美元** 利瑞克担任 PIPE 的独家配售代理","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","LU2362541273.HKD","LU2362541513.USD","LU2023250504.SGD","REGN","BUZZ","BK4588","LU0289739699.SGD","LU1974910355.USD","BK4585","LU2362540622.SGD","REPL","LU0053666078.USD","LU0320765992.SGD","BK4139","LU0889565916.HKD","LU2106854487.HKD","LU0882574055.USD","LU1917777945.USD","LU0058720904.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2442855758","title":"Replimune Group, Inc.盘中异动 早盘急速拉升5.44%报9.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442855758","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442855758?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:31","pubTimestamp":1718199110,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时31分，Replimune Group, Inc.股票出现波动，股价快速拉升5.44%。截至发稿，该股报9.49美元/股，成交量2.8691万股，换手率0.05%，振幅3.67%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Avidity Biosciences, Inc.、Molecular Partners Ag涨幅较大，Tonix Pharmaceuticals Holding Corp.、Tracon Pharmaceuticals, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为36.85%、19.08%、3.60%，振幅较大的相关个股有Passage Bio, Inc.、Xortx Therapeutics Inc.、Akari Therapeutics Plc，振幅分别为21.10%、20.93%、8.28%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221315096813b10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221315096813b10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2442316299","title":"Replimune Group, Inc.盘中异动 急速跳水5.09%报8.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442316299","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442316299?lang=zh_cn&edition=full","pubTime":"2024-06-12 00:04","pubTimestamp":1718121876,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日00时04分，Replimune Group, Inc.股票出现波动，股价大幅下挫5.09%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、Tc Biopharm  Plc C/Wts 10/02/2028 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Clearmind Medicine Inc.、Processa Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为154.13%、71.32%、30.34%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、180 Life Sciences Corp C/Wts 07/11/2025、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为482.47%、375.81%、47.59%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612000436aef45eb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612000436aef45eb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2442842685","title":"Replimune Group, Inc.盘中异动 股价大涨5.32%报8.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442842685","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442842685?lang=zh_cn&edition=full","pubTime":"2024-06-10 21:45","pubTimestamp":1718027151,"startTime":"0","endTime":"0","summary":"北京时间2024年06月10日21时45分，Replimune Group, Inc.股票出现波动，股价急速上涨5.32%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。消息层面，截至21时45分，《Form 144 | Replimune高管拟出售1.59万股股份，价值约11.92万美元》资讯为影响Replimune Group, Inc.的重要信息。该信息摘要如下：根据美国证券交易委员会美东时间6月7日披露的文件，$Replimune $高管Konstantinos Xynos拟于6月7日出售1.59万股普通股股份，总市值约11.92万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610214552aef42b9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610214552aef42b9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2441064820","title":"Replimune Group, Inc.盘中异动 急速下挫5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441064820","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441064820?lang=zh_cn&edition=full","pubTime":"2024-06-07 21:51","pubTimestamp":1717768299,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日21时51分，Replimune Group, Inc.股票出现异动，股价快速下挫5.34%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。消息层面，截至21时51分，《富瑞集团维持Replimune买入评级，下调目标价至12美元》资讯为影响Replimune Group, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060721514096812ef2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060721514096812ef2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2441551710","title":"Replimune Group, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441551710","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441551710?lang=zh_cn&edition=full","pubTime":"2024-06-06 21:31","pubTimestamp":1717680678,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日21时31分，Replimune Group, Inc.股票出现异动，股价大幅拉升5.04%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。消息层面，截至21时31分，《富瑞集团维持Replimune买入评级，下调目标价至12美元》资讯为影响Replimune Group, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606213118af8c6a1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606213118af8c6a1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2441256095","title":"Replimune Group, Inc.盘中异动 下午盘股价大跌5.06%报5.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441256095","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441256095?lang=zh_cn&edition=full","pubTime":"2024-06-05 01:56","pubTimestamp":1717523789,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日01时56分，Replimune Group, Inc.股票出现波动，股价急速跳水5.06%。截至发稿，该股报5.17美元/股，成交量32.6732万股，换手率0.53%，振幅6.43%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。消息层面，截至01时56分，《富瑞集团维持Replimune买入评级，下调目标价至12美元》资讯为影响Replimune Group, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605015630aef35965&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605015630aef35965&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL","ANNX"],"gpt_icon":0},{"id":"2440495325","title":"Replimune Group, Inc.盘中异动 早盘股价大涨5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440495325","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440495325?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:38","pubTimestamp":1717421916,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时38分，Replimune Group, Inc.股票出现波动，股价大幅上涨5.88%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。该公司使用专有的RPx平台来设计和开发候选产品，旨在最大限度地激活免疫系统，对抗实体肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213837af8ba71a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213837af8ba71a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2439997330","title":"Replimune Group, Inc.盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439997330","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439997330?lang=zh_cn&edition=full","pubTime":"2024-05-31 21:38","pubTimestamp":1717162691,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日21时38分，Replimune Group, Inc.股票出现异动，股价快速上涨5.10%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为1.19%。其相关个股中，Vaccinex, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Nutriband Inc C/Wts 涨幅较大，Scisparc Ltd.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Mymd Pharmaceuticals, Inc.较为活跃，换手率分别为49.16%、24.13%、14.04%，振幅较大的相关个股有Vaccinex, Inc.、Kintara Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为25.69%、11.96%、11.81%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531213812af8b66c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531213812af8b66c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REPL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.replimune.com","stockEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":0.1222},{"period":"3month","weight":0.5586},{"period":"6month","weight":0.285},{"period":"1year","weight":-0.5206},{"period":"ytd","weight":0.1981}],"compareEarnings":[{"period":"1week","weight":-0.0213},{"period":"1month","weight":-0.0041},{"period":"3month","weight":0.0832},{"period":"6month","weight":0.1079},{"period":"1year","weight":0.1839},{"period":"ytd","weight":0.1403}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Replimune Group, Inc.于2015年在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，致力于应用他们在溶瘤免疫治疗领域的领先专业技术，改变癌症患者的生活。使用该公司专有的Immulytic平台来设计和开发旨在最大限度激活免疫系统对抗癌症的候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.002034},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.066883},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.078936},{"month":4,"riseRate":0.5,"avgChangeRate":0.137961},{"month":5,"riseRate":0.5,"avgChangeRate":-0.043196},{"month":6,"riseRate":0.833333,"avgChangeRate":0.254496},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.060779},{"month":8,"riseRate":0.333333,"avgChangeRate":0.067123},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.049404},{"month":10,"riseRate":0.5,"avgChangeRate":0.124924},{"month":11,"riseRate":0.5,"avgChangeRate":0.010871},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.088051}],"exchange":"NASDAQ","name":"Replimune Group Inc.","nameEN":"Replimune Group Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.0","shortVersion":"4.26.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Replimune Group Inc.(REPL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Replimune Group Inc.(REPL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Replimune Group Inc.,REPL,Replimune Group Inc.股票,Replimune Group Inc.股票老虎,Replimune Group Inc.股票老虎国际,Replimune Group Inc.行情,Replimune Group Inc.股票行情,Replimune Group Inc.股价,Replimune Group Inc.股市,Replimune Group Inc.股票价格,Replimune Group Inc.股票交易,Replimune Group Inc.股票购买,Replimune Group Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Replimune Group Inc.(REPL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Replimune Group Inc.(REPL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}